About Reannon Pharma Limited
Data last updated:
Reannon Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PLC302728. Its GSTIN is 27AAICR6637D1Z8 (Maharashtra).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.82 Cr. It was formerly known as Reannon Pharmaceuticals India Limited and Reannon Pharmaceuticals India Private Limited. It is led by directors including Shobha Gole Bhimrao and Bhimrao Haribhau Gole.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 407 L.B.S. Marg Nirmal Corporate Center Mulund, Mumbai, Maharashtra, India – 400080.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reannonpharma.com.
Company details
Name history
Reannon Pharma has undergone 2 name changes throughout its history. The company was previously known as Reannon Pharmaceuticals India Limited, and Reannon Pharmaceuticals India Private Limited. The current legal name is Reannon Pharma Limited.
| Company Name | Status |
|---|---|
| Reannon Pharma Limited | Current |
| Reannon Pharmaceuticals India Limited | Previous |
| Reannon Pharmaceuticals India Private Limited | Previous |
CIN history
Reannon Pharma has one previous CIN (Corporate Identification Number): U74999MH2017PTC302728. The current CIN is U74999MH2017PLC302728, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999MH2017PLC302728 | Current |
| U74999MH2017PTC302728 | Previous |
Contact details
Reannon Pharma Limited's registered office is in Mumbai, Maharashtra. Its website is reannonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 407 L.B.S. Marg Nirmal Corporate Center Mulund, Mumbai, Maharashtra, India – 400080
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Reannon Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reannon Pharma Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reannon Pharma Limited, buy the company report.
Board of directors of Reannon Pharma Limited
Reannon Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobha Gole Bhimrao | Director | 11 Dec 2017 | 8 Years 10 Months | Current |
| Bhimrao Haribhau Gole Also directs: Reannon Impex Private Limited | Director | 19 Mar 2019 | 7 Years 7 Months | Current |
| Hrishikesh Bhimrao Gole Also directs: Reannon Impex Private Limited | Director | 11 Dec 2017 | 8 Years 10 Months | Current |
Auditor
Reannon Pharma Limited is audited by Rajkumar Jaiswal & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajkumar Jaiswal & Company | FY 2023 | 124064 |
Shareholding
The shareholding of Reannon Pharma Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Reannon Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reannon Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reannon Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reannon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR6637D1Z8 | Maharashtra | Active | 21 Feb 2019 |
To see the full GST registrations and return filing status of Reannon Pharma Limited, buy the company report.
Recent activity
Reannon Pharma Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Bhimrao Haribhau Gole ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Reannon Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 December 2017 (9+ years old) and is registered under CIN U74999MH2017PLC302728.
Reannon Pharma has 3 current directors:
- Shobha Gole Bhimrao - Director
- Bhimrao Haribhau Gole - Director
- Hrishikesh Bhimrao Gole - Director
The latest financial statements of Reannon Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Reannon Pharma is 27AAICR6637D1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reannon Pharma is U74999MH2017PLC302728. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reannon Pharma was incorporated on 11 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Bhimrao Haribhau Gole ceased to be Additional Director on 30 Sep 2019. Bhimrao Haribhau Gole was appointed as Director on 19 Mar 2019. Hrishikesh Bhimrao Gole was appointed as Director on 11 Dec 2017. Reannon Pharma has 4 board changes on record in total.
Reannon Pharma can be reached through the website reannonpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Reannon Pharma is at Unit No. 407 L.B.S. Marg Nirmal Corporate Center Mulund, Mumbai, Maharashtra, India – 400080.
Reannon Pharma operates in the pharma industry, in the drug formulation and development segment.